Organising the language of Alzheimer's disease in light of biomarkers

The Lancet Neurology

Volumn 9, Issue 11, 2010, Pages 1044-1045

  Schneider, Lon S ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; CLINICAL FEATURE; COGNITION; DEMENTIA; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE COURSE; EPISODIC MEMORY; LANGUAGE; LETTER; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; HUMANS; LANGUAGE;

EID: 77957940723     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70246-5     Document Type: Letter

References (7)

1. Hardy J, Allsop D Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991, 12:383-388.
2. Flicker C, Ferris SH, Reisberg B Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991, 41:1006-1009.
3. Morris JC, McKeel DW, Storandt M, et al. Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991, 41:469-478.
4. De Leon M, George A, Stylopoulos L, Smith G, Miller D Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 1989, 334:672-673.
5. Braak H, Braak E Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
6. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006, 66:1837-1844.
7. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010, published online Oct 11. 10.1016/S1474-4422(10)70223-4.